Literature DB >> 8648354

Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening.

J Jankovic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8648354      PMCID： PMC1073973          DOI： 10.1136/jnnp.60.6.704

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  2 in total

1.  Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia.

Authors:  J Jankovic; K S Schwartz
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

2.  Pretarsal application of botulinum toxin for treatment of blepharospasm.

Authors:  M Aramideh; B W Ongerboer de Visser; J W Brans; J H Koelman; J D Speelman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154
  2 in total
  10 in total

Review 1.  Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases.

Authors:  S Jitpimolmard; S Tiamkao; M Laopaiboon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

2.  Use of Botulinum Toxin in Ophthalmology.

Authors:  Michael J Wan; Sara AlShaker; David G Hunter
Journal:  Handb Exp Pharmacol       Date:  2021

3.  Current and future treatments in progressive supranuclear palsy.

Authors:  Irene van Balken; Irene Litvan
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.598

4.  Development of a Clinical Rating Scale for the Severity of Apraxia of Eyelid Opening, Either Isolated or Associated with Blepharospasm.

Authors:  Gina Ferrazzano; Antonella Muroni; Antonella Conte; Tommaso Ercoli; Giorgio Tamburini; Giovanni Fabbrini; Alfredo Berardelli; Giovanni Defazio
Journal:  Mov Disord Clin Pract       Date:  2020-09-22

5.  Botulinum toxin type A therapy for blepharospasm.

Authors:  Gonçalo S Duarte; Filipe B Rodrigues; Raquel E Marques; Mafalda Castelão; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2020-11-19

Review 6.  Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.

Authors:  C Kenney; J Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2007-06-11       Impact factor: 3.575

7.  Available and future treatments for atypical parkinsonism. A systematic review.

Authors:  Davide Vito Moretti
Journal:  CNS Neurosci Ther       Date:  2018-10-07       Impact factor: 5.243

8.  Apraxia of Lid Opening in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease-Frequency, Risk Factors and Response to Treatment.

Authors:  Syam Krishnan; Kuldeep Shetty; Divya Kalikavil Puthanveedu; Krishnakumar Kesavapisharady; Jissa Vinoda Thulaseedharan; Gangadhara Sarma; Asha Kishore
Journal:  Mov Disord Clin Pract       Date:  2021-04-12

9.  Botulinum toxin injections for blepharospasm prior to ocular surgeries.

Authors:  Seydi Okumus; Erol Coskun; Ibrahim Erbagci; M Gürkan Tatar; Aysegul Comez; Erdal Kaydu; Ramazan Yayuspayi; Bulent Gurler
Journal:  Clin Ophthalmol       Date:  2012-05-03

Review 10.  Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options.

Authors:  Ruth Lamb; Jonathan D Rohrer; Andrew J Lees; Huw R Morris
Journal:  Curr Treat Options Neurol       Date:  2016-09       Impact factor: 3.598
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.